Loading clinical trials...
Loading clinical trials...
The Halland Osteoarthritis (HALLOA) Cohort Study - a Five-year Observational Longitudinal Study With Focus on Metabolic Osteoarthritis
Conditions
Locations
1
Sweden
Spenshult Research and Development center (FoU Spenshult)
Halmstad, Sweden
Start Date
November 1, 2016
Primary Completion Date
October 1, 2019
Completion Date
December 1, 2024
Last Updated
October 1, 2024
NCT07217405
NCT05986292
NCT06234631
NCT07364578
NCT06488144
NCT07058623
Lead Sponsor
FoU Center Spenshult
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions